- Home
- NVGS vs BHVN Comparison
NVGS vs BHVN Comparison
Compare NVGS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- BHVN
- Stock Information
- Founded
- NVGS 1997
- BHVN 2013
- Country
- NVGS United Kingdom
- BHVN United States
- Employees
- NVGS N/A
- BHVN N/A
- Industry
- NVGS Marine Transportation
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- NVGS Consumer Discretionary
- BHVN Health Care
- Exchange
- NVGS Nasdaq
- BHVN Nasdaq
- Market Cap
- NVGS 1.1B
- BHVN 1.1B
- IPO Year
- NVGS N/A
- BHVN 2017
- Fundamental
- Price
- NVGS $17.81
- BHVN $9.41
- Analyst Decision
- NVGS Strong Buy
- BHVN Strong Buy
- Analyst Count
- NVGS 2
- BHVN 16
- Target Price
- NVGS $21.50
- BHVN $35.07
- AVG Volume (30 Days)
- NVGS 322.3K
- BHVN 6.0M
- Earning Date
- NVGS 11-04-2025
- BHVN 11-10-2025
- Dividend Yield
- NVGS 1.57%
- BHVN N/A
- EPS Growth
- NVGS 33.99
- BHVN N/A
- EPS
- NVGS 1.50
- BHVN N/A
- Revenue
- NVGS $578,158,000.00
- BHVN N/A
- Revenue This Year
- NVGS $1.23
- BHVN N/A
- Revenue Next Year
- NVGS $3.02
- BHVN $2,079.03
- P/E Ratio
- NVGS $12.00
- BHVN N/A
- Revenue Growth
- NVGS 2.46
- BHVN N/A
- 52 Week Low
- NVGS $10.55
- BHVN $7.48
- 52 Week High
- NVGS $17.99
- BHVN $47.75
- Technical
- Relative Strength Index (RSI)
- NVGS 68.11
- BHVN 37.08
- Support Level
- NVGS $17.47
- BHVN $7.48
- Resistance Level
- NVGS $17.99
- BHVN $9.70
- Average True Range (ATR)
- NVGS 0.44
- BHVN 1.06
- MACD
- NVGS 0.09
- BHVN -0.20
- Stochastic Oscillator
- NVGS 90.37
- BHVN 19.11
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.